南方医科大学学报 ›› 2016, Vol. 36 ›› Issue (03): 405-.

• • 上一篇    下一篇

多囊卵巢综合征合并不孕症患者血清TOS,TAS水平变化及其与血浆载脂蛋白(a)的关系

涂铵素,钟影,毛熙光   

  • 出版日期:2016-03-20 发布日期:2016-03-20

Changes of serum TOS and TAS levels and their association with apolipoprotein(a) in patients with polycystic ovary syndrome and infertility

  • Online:2016-03-20 Published:2016-03-20

摘要: 目的探讨多囊卵巢综合征(polycystic ovary syndrome, PCOS)合并不孕症患者血清总氧化态(TOS),总抗氧化态(TAS) 水平变化及其与血浆载脂蛋白(a)[Apo(a)]的关系。方法选取我院PCOS合并不孕症患者90例作为研究组,其中采用抗氧化 剂联合达因-35治疗患者作为A组(45例),采用达因-35治疗患者作为B组(45例),同期选取月经正常,基础体温双相的健康自 愿者45例作为对照组,采用二甲酚橙法测定血清TOS水平,采用ABTS法测定血清TAS水平,采用双波长免疫透射比浊法测定 血浆Apo(a)水平。组间比较TOS 、TAS、OSI(TOS/TAS)与Apo(a)水平的差异,并采用Pearson相关性分析TOS 、TAS、OSI与 Apo(a)指标间的关系。结果治疗前,研究组血清TOS,OSI、血浆Apo(a)水平明显高于对照组,TAS水平明显低于对照组,比较 差异具有统计学意义(P<0.05),治疗后,A组血清TOS,血浆Apo(a)水平明显低于治疗前与B组,TAS水平明显高于治疗前与B 组,月经自然恢复率明显高于B组,心血管疾病发生率明显低于B组,比较差异具有统计学意义(P<0.05)。经Pearson相关性分 析,血清TOS、OSI与血浆Apo(a)水平呈正相关(r=0.524,0.531,P<0.05);血清TAS水平与血浆Apo(a)水平呈负相关(r=-0.519, P<0.05)。结论抗氧化剂治疗通过显著降低TOS、OSI、Apo(a)水平与增高TAS水平,从而显著降低机体氧化应激损伤程度,改 善PCOS合并不孕症患者预后与并发心血管疾病发生风险。

Abstract: Objective To investigate changes of serum total oxidation status (TOS) and total antioxidant status (TAS) and their association with apolipoprotein (a) [Apo(a)] in patients with polycystic ovary syndrome (PCOS) combined with infertility. Methods Ninety patients with PCOS and infertility were selected as the study group, including 45 patients treated with antioxidants combined with Diane-35(group A) and 45 with Diane-35 therapy only (group B), with 45 healthy volunteers with normal menstruation and normal dual phase basic body temperatures as the control group. Serum TOS of the participants was determined by dual xylenol orange method, and serum TAS was determined with ABTS method; plasma Apo(a) level was determined by dual wavelength immune transmission turbidity method. Results Before treatment, serum TOS, OSI, and Apo (a) levels were significantly higher and TAS level was significantly lower in the study group than in the control group (P<0.05). Serum TOS, OSI, and Apo (a) were significantly lowered and TAS was significantly increased in group A after the therapy as compared with the levels before therapy and the levels in group B. The rate of natural recovery of menstruation was significantly higher and the incidence of cardiovascular disease was significantly lower in group A than in group B (P<0.05). Pearson correlation analysis showed that serum TOS and OSI were positively correlated with plasma Apo(a) (r=0.524 and 0.531, P<0.05), and serum TAS was negatively correlated with plasma Apo(a) (r=-0.519, P<0.05). Conclusion Antioxidant therapy can lower TOS, OSI and Apo(a) levels and increase TAS level to lessen oxidative stress, improve the prognosis, and reduce the risks of cardiovascular disease in patients with PCOS and infertility.